A carregar...
A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma
BACKGROUND: Ovarian cancer is the most fatal tumor of the female reproductive system and the fifth leading cause of cancer death among women in the USA. The prognosis is poor due to the lack of biomarkers for treatment options. RESULTS: The methylation array data of 551 patients with ovarian serous...
Na minha lista:
| Publicado no: | Clin Epigenetics |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6240326/ https://ncbi.nlm.nih.gov/pubmed/30446011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-018-0574-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|